A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia

Annals of the Rheumatic Diseases

Volumn 72, Issue 5, 2013, Pages 638-645

  Chowalloor, Priya V ^a,b   Keen, Helen Isobel ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ARTICULAR CARTILAGE; CLINICAL TRIAL (TOPIC); COLOR ULTRASOUND FLOWMETRY; CONSERVATIVE TREATMENT; CONSTRUCT VALIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEASIBILITY STUDY; GOUT; HUMAN; HYPERURICEMIA; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; JOINT RADIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE; SYNOVIUM; SYSTEMATIC REVIEW;

ARTHRITIS, GOUTY; ASYMPTOMATIC DISEASES; GOUT; HUMANS; HYPERURICEMIA; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 84875957784     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202301     Document Type: Review

References (39)

1. Tausche AK, Jansen TL, Schröder HE, et al. Gout - current diagnosis and treatment. Dtsch Arztebl Int 2009;106:549-55.
2. Abbott RD, Brand FN, Kannel WB, et al. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988;41:237-42. (Pubitemid 18069583)
3. Krishnan E, Svendsen K, Neaton JD, et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008;168:1104-10. (Pubitemid 351749228)
4. Krishnan E, Baker JF, Furst DE, et al. Gout and the risk of acute myocardial infarction. ArthritisRheum 2006;54:2688-96. (Pubitemid 44208638)
5. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116:894-900. (Pubitemid 47300913)
6. Fraile JM, Torres RJ, de Miguel ME, et al. Metabolic syndrome characteristics in gout patients. Nucleosides Nucleotides Nucleic Acids 2010;29:325-9.
7. Kuo CF, See LC, Luo SF, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology 2010;49:141-6.
8. Wall GC, Koenigsfeld CF, Hegge KA, et al. Adherence to treatment guidelines in two primary care populations with gout. Rheumatol Int 2010;30:749-53.
9. Pal B, Foxall M, Dysart T, et al. How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 2000;19:21-5. (Pubitemid 30123236)
10. Dabath N, McQueen FM. Use of imaging to evaluate gout and other crystal deposition diseases. Curr Opin Rheumatol 2009;21:124-31.
11. Mandl P, Naredo E, Wakefield RJ, et al. OMERACT Ultrasound Task Force. A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 2011;38:2055-62.
12. Joshua F, Edmonds J, Lassere M. Power Doppler ultrasound in musculoskeletal disease: a systematic review. Semin Arthritis Rheum 2006;36:99-108. (Pubitemid 44488591)
13. Joshua F, Lassere M, Bruyn GA, et al. Summary findings of a systematic review of the ultrasound assessment of synovitis. J Rheumatol 2007;34:839-47. (Pubitemid 46641395)
14. Keen HI, Conaghan PG. Ultrasonography in osteoarthritis. PG Radiol Clin North Am 2009;47:581-94.
15. Boers M, Brooks P, Simon LS, et al. OMERACT: an international initiative to improve outcome measurement in rheumatology. Clin Exp Rheumatol 2005;23(Suppl. 39): S10-13. (Pubitemid 46657506)
16. Nalbant S, Corominas H, Hsu B, et al. Ultrasonography for assessment of subcutaneous nodules. J Rheumatol 2003;30:1191-95. (Pubitemid 36666339)
17. Perez-Ruiz F, Martin I, Canteli B. Ultrasonographic Measurement of Tophi as an Outcome Measure for Chronic Gout. J Rheumatol 2007;34:1888-93. (Pubitemid 350067651)
18. Thiele RG, Schlesinger N. Diagnosis of gout by ultrasound. Rheumatology (Oxford) 2007;46:1116-12.
19. Wright SA, Filippucci E, McVeigh C, et al. High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study. Ann Rheum Dis 2007;66:859-64. (Pubitemid 46999784)
20. Schueller-Weidekamm C, Schueller G, Aringer M, et al. Impact of sonography in gouty arthritis: comparison with conventional radiography, clinical examination, and laboratory findings. Eur J Radiol 2007;62:437-43. (Pubitemid 46783359)
21. Rettenbacher T, Ennemoser S, Weirich H, et al. Diagnostic imaging of gout. Comparison of high-resolution US versus conventional X-ray. Eur Radiol 2008;18:621-30.
22. Puig JG, de Miguel E, Castillo MC, et al. Asymptomatic hyperurecemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 2008;27:592-5.
23. Carter JD, Kedar RP, Anderson SR, et al. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology 2009;48:1442-6.
24. Filippucci E, Gutierrez M, Georgescu D, et al. Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease: an ultrasound study. Osteoarthritis Cartilage 2009;17:178-81.
25. Thiele RG, Schlesinger N. Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved. Rheumatol Int 2010;30:495-503.
26. de Ávila Fernandes E, Sandim GB, Mitraud SAV, et al. Sonographic description and classification of tendinous involvement in relation to tophi in chronic tophaceous gout. Insights Imaging 2010;1:143-8.
27. Filippucci E, Scirè CA, Sedie D, et al. Ultrasound imaging for the rheumatologist XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol 2010;28:2-5.
28. de Ávila Fernandes E, Kubota ES, Sandim GB, et al. Ultrasound features of tophi in chronic tophaceous gout. Skeletal Radiol 2011;40:309-15.
29. Howard RG, Pillinger MH, Gyftopoulos S, et al. Reproducibility of Musculoskeletal Ultrasound for Determining Monosodium Urate Deposition: concordance between readers. Arthritis Care Res 2011;63:1456-62.
30. Ottaviani S, Allard A, Bardin T, et al. An exploratory ultrasound study of early gout. Clin Exp Rheumatol 2011;29:816-21.
31. Filippucci E, Meenagh G, Sedie AD, et al. Ultrasound imaging for the rheumatologist XXXVI. Sonographic assessment of the foot in gout patients. Clin Exp Rheumatol 2011;29:901-5.
32. Pineda C, Amezcua-Guerra LM, Solano C, et al. Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 2011;13:R4:1-7.
33. De Miguel E, Puig J, Castillo C, et al. Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study. Ann Rheum Dis January 2012;71:157-8.
34. Dalbeth N, Doyle A, McQueen FM. Imaging in gout: insights into the pathological features of disease. Curr Opin Rheumatol 2012;24:132-8.
35. Grassi W, Meenagh G, Pascual E, et al. "Crystal clear" - sonographic assessment of gout and calcium pyrophosphate deposition disease. Semin Arthritis Rheum 2006;36:197-202. (Pubitemid 44691886)
36. Wakefield R. All that glimmers is not gold. Semin Arthritis Rheum 2007;37: 133-4. (Pubitemid 350198585)
37. Naredo E, Wakefield RJ, Iagnocco A, et al. The OMERACT ultrasound task force - status and perspectives. J Rheumatol 2011;38:2063-7.
38. Scheel K, Hermann KG, Ohrndorf S, et al. Prospective 7-year follow-up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann Rheum Dis 2006;65: 595-600.
39. Backhaus M, Burmester GR, Sandrock D, et al. Prospective two-year follow-up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 2002;61:895-904.